Corista, LLC — SEC Form D Filing

Corista, LLC filed an SEC Form D on June 25, 2026, reporting $50K raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
June 25, 2026
Amount reported
$50K
Industry
Health Technology
Website
https://corista.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: MASSACHUSETTS

Problem

Pathology stakeholders face demanding workflow challenges related to managing digital image data, analysis, annotations, and collaboration, often limited by geographic barriers and connectivity issues.

Solution

Corista provides DP3, an image management platform that integrates and accelerates digital pathology workflows by centralizing digital image data, optimizing analysis and annotations, and enabling peer-to-peer collaboration.

Why now

The increasing adoption of digital pathology, coupled with advancements in AI and the need for more efficient diagnostic workflows, creates a critical demand for integrated image management and collaboration platforms in healthcare and life sciences.

Verdict

Investors backed this because it promised to bring digital workflow efficiencies to a deeply manual medical specialty, not because it presented a truly novel technological breakthrough. The implicit bet was on rapid, widespread adoption of digital pathology infrastructure. Upside was limited by the reliance on slow-moving healthcare capital expenditure cycles and the established competition already integrating similar digital solutions into their broader diagnostic portfolios.

Source: SEC EDGAR Form D filing